2018 Section 6 - Laryngology, Voice Disorders, and Bronchoesophalogy

with MDR tuberculosis that is closely associated with high antigen load. J Infect Dis 2011;204:1054–1064. 34. Grillo HC, Mark EJ, Mathisen DJ, Wain JC. Idiopathic laryngotracheal stenosis and its management. Ann Thorac Surg 1993;56:80–87. 35. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 1990;323:1573–1580. 36. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992;327:293– 301. 37. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Sci- ence 1993;262:914–917. 38. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coro- navirus associated with severe acute respiratory syndrome. Science 2003;300:1394–1399. 39. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associ- ated with severe acute respiratory syndrome. N Engl J Med 2003;348: 1953–1966. 40. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in sys- temic sarcoidosis. J Exp Med 2005;201:755–767. 41. David HL. Bacteriology of the Mycobacterioses. Atlanta, GA: US Dept. of Health, Education, and Welfare, Public Health Service, and Center for Disease Control, 1978. 42. Portaels F, Agular J, Fissette K, et al. Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 1997;35:1097–1100. 43. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006;100:610–615. 44. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863–868. 45. Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002;70:336–348. 46. Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis dissemi- nated infection. J Clin Invest 1998;102:2035–2040. 47. Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resist- ance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003;197:527–535. 48. de Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Med- icine (Baltimore) 2010;89:381–402. 49. Newcomb DC, Cephus JY, Boswell MG, et al. Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma. J Allergy Clin Immunol 2015;136:1025–1034.e11. 50. Silva JC, Mariz HA, Rocha LF Jr, et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheuma- toid arthritis patients. Clinics (Sao Paulo) 2013;68:766–771. 51. Griffiths CE, Reich K, Lebwohl M, et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 2015; 386:541–551. 52. Lebwohl M, Strober B, Menter A, et al. Phase 3 studies comparing Broda- lumab with Ustekinumab in psoriasis. N Engl J Med 2015;373:1318– 1328.

15. Drake WP, Newman LS. Mycobacterial antigens may be important in sar- coidosis pathogenesis. Curr Opin Pulm Med 2006;12:359–363. 16. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780–13785. 17. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythro- mycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732– 1736. 18. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Esche- richia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998;178:446–450. 19. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, Kolter R. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 2010;1. pii: e00129-10. doi: 10.1128/mBio.00129- 10. 20. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bac- terial community variation in human body habitats across space and time. Science 2009;326:1694–1697. 21. Gelbard A, Katsantonis NG, Mizuta M, et al. Idiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL23 axis. Laryngoscope 2016. 22. Nouraei SA, Sandhu GS. Outcome of a multimodality approach to the management of idiopathic subglottic stenosis. Laryngoscope 2013;123: 2474–2484. 23. Verhelst R, Verstraelen H, Claeys G, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004;4:16. 24. Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PloS One 2012;7:e33865. 25. Wang F, Flanagan J, Su N, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2012;14:22–29. 26. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for Mycobacterium species DNA. Emerg Infect Dis 2002;8:1334–1341. 27. Parekh VV, Wu L, Boyd KL, et al. Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific dele- tion of Vps34. J Immunol 2013;190:5086–5101. 28. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of Mycobacte- rium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007;75:527–530. 29. Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009;37: 2360–2368. 30. Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994;38: 773–780. 31. Carlisle J, Evans W, Hajizadeh R, et al. Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 2007;150:460–468. 32. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gam- madelta T cells rather than CD4 T cells during Mycobacterium tubercu- losis infection. J Immunol 2006;177:4662–4669. 33. Basile JI, Geffner LJ, Romero MM, et al. Outbreaks of Mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients

Laryngoscope 127: January 2017

Gelbard et al.: iSGS Is Associated With Mtb

232